Beijing Dikang Pharmaceutical Investment Management Co., Ltd.(Healtech Beijing CDMO Centre), founded in 2014, is dedicated to the field of regenerative medicine biomaterials, creating a service platform for the whole industry chain in the field of tissue engineering and regenerative medicine.We provide one-stop CDMO solutions such as research and development, registration and testing, animal experiment, clinical trial, registration declaration, commissioned production, and commercial solutions for production and sales-oriented enterprises.

The company has 3000 square metres of GMP clean workshop and R&D laboratory, and plans a variety of space for production area, experimental area, storage area and office area. A team of experts from Academy of Military Medical Sciences and Beijing Jiaotong University serve as technical consultants, gathering experts and professionals in biomaterials, medicine and pharmacy.The Tissue Engineering and Regenerative Medicine Biomaterials Laboratory undertakes the special project of "National 13th Five Year Key R&D Plan for Biomaterials Research and Development and Organ Repair Replacement", realizing the transformation of scientific and technological achievements in "Engineering preparation technology and product development of low immunogenicity collagen and silk fibroin protein", and further reserving various research and development technologies of new generation mainstream medical materials such as hyaluronic acid, PLA, PLLA, pectin, PCL, peptides, polyethylene, PVA, polyurethane, polytetrafluoroethylene, microcrystalline calcium, chitosan, hydroxyapatite, humanized collagen, etc.We accomplished the breakthrough of a number of original innovation achievements from 0 to 1.

On 9th May, 2023, based on the "13th Five-Year Plan" transformation of the retinal decellularised extracellular matrix related products obtained the first class Ⅲ medical device registration certificate approved by National Medical Products Administration (National Medical Device Registration 20233140615), which is the first class Ⅲ collagen dressing prepared from collagen derived from decellularised extracellular matrix as raw material. It is likewise the first Class Ⅲ medical device registration certificate born from entrusted research and development in the device CRO&CDMO industry.

The company has won many honours such as "National High-tech Enterprise", "Zhongguancun High-tech Enterprise", "Beijing Innovative Small and Medium-sized Enterprise", and "Beijing ‘Specialized and Sophisticated’ Small and Medium-sized Enterprise". In 2018, we won the special support of Zhongguancun Demonstration Zone for the cultivation of high-precision industries. At present, we have reserved more than 30 technical projects, obtained five national invention patent certificates, and three medical device registration certificates, three China's first scientific research achievements, and completed one medical device raw material master file registration, which will continue to create new value for health.